Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.160
-0.030 (-2.52%)
Jul 7, 2025, 4:00 PM - Market closed

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $253.73 million as of July 7, 2025. Its market cap has decreased by -47.16% in one year.

Market Cap
253.73M
Enterprise Value
62.61M
1-Year Change
-47.16%
Ranking
Category
Stock Price
$1.16

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $253.73M, a decrease of -91.19%. That is a compound annual growth rate of -30.30%.

History

DateMarket Cap% Change
Jul 3, 2025260.29M-41.72%
Dec 31, 2024446.60M-17.32%
Dec 29, 2023540.17M-40.45%
Dec 30, 2022907.08M-57.34%
Dec 31, 20212.13B-39.95%
Dec 31, 20203.54B11.80%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 700.84B
Johnson & Johnson 375.37B
AbbVie 334.34B
Novo Nordisk 316.33B
UnitedHealth Group 279.90B
Novartis AG 242.35B
Abbott Laboratories 233.90B
AstraZeneca 218.65B
Market Cap Rankings